Stay updated on Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error, replacing the study details and navigation with an access-denied notice. This indicates restricted access rather than an update to the study data.
    Difference
    17%
    Check dated 2026-09-20T22:56:58.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Footer revision text updated from v3.6.5 to v3.6.6, signaling a recent site update.
    Difference
    0.0%
    Check dated 2026-08-30T16:50:40.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    The page now displays revision v3.6.5, replacing v3.6.4, indicating an update to the page's underlying template or build. This is an internal version update and does not alter the study details or visible content.
    Difference
    0.0%
    Check dated 2026-08-09T09:14:06.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The page shows Revision: v3.6.4 instead of v3.6.3, indicating a newer page build while leaving study details unchanged.
    Difference
    0.0%
    Check dated 2026-07-25T18:16:16.000Z thumbnail image
  7. Check
    98 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.3, replacing the previous v3.6.2, reflecting a minor version update to the page.
    Difference
    0.0%
    Check dated 2026-07-04T13:28:57.000Z thumbnail image
  8. Check
    106 days ago
    Change Detected
    Summary
    The page now shows a newer site revision label (v3.6.2) replacing the previous v3.6.0. This appears to be a minor UI/site maintenance update and does not affect the study details or data displayed on the page.
    Difference
    0.0%
    Check dated 2026-06-27T08:09:43.000Z thumbnail image

Stay in the know with updates to Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial page.